TY - JOUR
T1 - Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis
T2 - An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study
AU - See, Emily J.
AU - Johnson, David W.
AU - Hawley, Carmel M.
AU - Pascoe, Elaine M.
AU - Badve, Sunil V.
AU - Boudville, Neil
AU - Clayton, Philip A.
AU - Sud, Kamal
AU - Polkinghorne, Kevan R.
AU - Borlace, Monique
AU - Cho, Yeoungjee
N1 - Funding Information:
Support: Dr Johnson is supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship. Dr Cho is supported by a NHMRC Early Career Development Fellowship. Data used in this study was obtained from ANZDATA, which is funded by the Australian Organ and Tissue Donation and Transplantation Authority, the New Zealand Ministry of Health, and Kidney Health Australia. The sources of support had no role in study design; collection, analysis, and interpretation of data; manuscript preparation; or the decision to submit for publication.
Funding Information:
Financial Disclosure: Dr Johnson has received consultancy fees, speaker’s honoraria, travel sponsorships, and research grants from Baxter Healthcare and Fresenius Medical Care. Dr Hawley has received research grant support from Amgen, Shire, and Baxter and consulting and advisory fees from Shire and Amgen. Dr Sud has received speaker’s honoraria from Baxter Healthcare, Roche, Amgen, and Boehringer Ingelheim and conference or meeting sponsorships from Shire, Roche, Boehringer Ingelheim, Amgen, Sanofi, and Novartis. Dr Boudville has received consultancy fees from Astra Zeneca and travel grants from Roche and Amgen. Dr Cho has received research grants from Baxter Healthcare and Fresenius Medical Care. The other authors declare that they have no other relevant financial interests.
Publisher Copyright:
© 2017
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/8
Y1 - 2018/8
N2 - Background: Concern regarding technique failure is a major barrier to increased uptake of peritoneal dialysis (PD), and the first year of therapy is a particularly vulnerable time. Study Design: A cohort study using competing-risk regression analyses to identify the key risk factors and risk periods for early transfer to hemodialysis therapy or death in incident PD patients. Setting & Participants: All adult patients who initiated PD therapy in Australia and New Zealand in 2000 through 2014. Predictors: Patient demographics and comorbid conditions, duration of prior renal replacement therapy, timing of referral, PD modality, dialysis era, and center size. Outcomes: Technique failure within the first year, defined as transfer to hemodialysis therapy for more than 30 days or death. Results: Of 16,748 patients included in the study, 4,389 developed early technique failure. Factors associated with increased risk included age older than 70 years, diabetes or vascular disease, prior renal replacement therapy, late referral to a nephrology service, or management in a smaller center. Asian or other race and use of continuous ambulatory PD were associated with reduced risk, as was initiation of PD therapy in 2010 through 2014. Although the risk for technique failure due to death or infection was constant during the first year, mechanical and other causes accounted for a greater number of cases within the initial 9 months of treatment. Limitations: Potential for residual confounding due to limited data for residual kidney function, dialysis prescription, and socioeconomic factors. Conclusions: Several modifiable and nonmodifiable factors are associated with early technique failure in PD. Targeted interventions should be considered in high-risk patients to avoid the consequences of an unplanned transfer to hemodialysis therapy or death.
AB - Background: Concern regarding technique failure is a major barrier to increased uptake of peritoneal dialysis (PD), and the first year of therapy is a particularly vulnerable time. Study Design: A cohort study using competing-risk regression analyses to identify the key risk factors and risk periods for early transfer to hemodialysis therapy or death in incident PD patients. Setting & Participants: All adult patients who initiated PD therapy in Australia and New Zealand in 2000 through 2014. Predictors: Patient demographics and comorbid conditions, duration of prior renal replacement therapy, timing of referral, PD modality, dialysis era, and center size. Outcomes: Technique failure within the first year, defined as transfer to hemodialysis therapy for more than 30 days or death. Results: Of 16,748 patients included in the study, 4,389 developed early technique failure. Factors associated with increased risk included age older than 70 years, diabetes or vascular disease, prior renal replacement therapy, late referral to a nephrology service, or management in a smaller center. Asian or other race and use of continuous ambulatory PD were associated with reduced risk, as was initiation of PD therapy in 2010 through 2014. Although the risk for technique failure due to death or infection was constant during the first year, mechanical and other causes accounted for a greater number of cases within the initial 9 months of treatment. Limitations: Potential for residual confounding due to limited data for residual kidney function, dialysis prescription, and socioeconomic factors. Conclusions: Several modifiable and nonmodifiable factors are associated with early technique failure in PD. Targeted interventions should be considered in high-risk patients to avoid the consequences of an unplanned transfer to hemodialysis therapy or death.
KW - ANZDATA
KW - Death
KW - end-stage kidney disease (ESKD)
KW - peritoneal dialysis (PD)
KW - peritonitis
KW - renal replacement therapy (RRT)
KW - RRT modality switch
KW - technique failure
KW - transfer to hemodialysis
UR - https://www.scopus.com/pages/publications/85038829230
U2 - 10.1053/j.ajkd.2017.10.019
DO - 10.1053/j.ajkd.2017.10.019
M3 - Article
C2 - 29277508
AN - SCOPUS:85038829230
SN - 0272-6386
VL - 72
SP - 188
EP - 197
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -